207 related articles for article (PubMed ID: 27579723)
1. [Systemic therapy of breast cancer: practice guideline].
Horváth Z; Boér K; Dank M; Kahán Z; Kocsis J; Kövér E; Pajkos G; Pikó B; Rubovszky G; Eckhardt S
Magy Onkol; 2016 Sep; 60(3):241-57. PubMed ID: 27579723
[TBL] [Abstract][Full Text] [Related]
2. [Systemic treatment of early breast cancer - current state of knowledge after the conference St Gallen 2017].
Sarosiek T
Pol Merkur Lekarski; 2017 Nov; 43(257):232-236. PubMed ID: 29231918
[TBL] [Abstract][Full Text] [Related]
3. [Systemic treatment of breast cancer: professional guideline].
Horváth Z; Boér K; Dank M; Kahán Z; Kocsis J; Kövér E; Máhr K; Pikó B; Rubovszky G
Magy Onkol; 2020 Dec; 64(4):348-368. PubMed ID: 33313610
[TBL] [Abstract][Full Text] [Related]
4. [Adjuvant chemotherapy for primary breast cancer--review of 1998 St. Gallen's conference].
Taguchi T
Gan To Kagaku Ryoho; 1999 Aug; 26(9):1227-41. PubMed ID: 10478174
[TBL] [Abstract][Full Text] [Related]
5. Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.
Rubovszky G; Kocsis J; Boér K; Chilingirova N; Dank M; Kahán Z; Kaidarova D; Kövér E; Krakovská BV; Máhr K; Mriňáková B; Pikó B; Božović-Spasojević I; Horváth Z
Pathol Oncol Res; 2022; 28():1610383. PubMed ID: 35898593
[TBL] [Abstract][Full Text] [Related]
6. NCCN breast cancer clinical practice guidelines in oncology: an update.
Carlson RW
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S61-3. PubMed ID: 19795577
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer: overview & updates.
Downs-Holmes C; Silverman P
Nurse Pract; 2011 Dec; 36(12):20-6; quiz 7. PubMed ID: 22089837
[TBL] [Abstract][Full Text] [Related]
8. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
9. ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3).
Paluch-Shimon S; Pagani O; Partridge AH; Abulkhair O; Cardoso MJ; Dent RA; Gelmon K; Gentilini O; Harbeck N; Margulies A; Meirow D; Pruneri G; Senkus E; Spanic T; Sutliff M; Travado L; Peccatori F; Cardoso F
Breast; 2017 Oct; 35():203-217. PubMed ID: 28822332
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant systemic therapy for lymph node-negative breast cancer less than or equal to 1 cm.
Russell CA
Curr Womens Health Rep; 2002 Apr; 2(2):134-9. PubMed ID: 12116603
[TBL] [Abstract][Full Text] [Related]
11. Update: breast cancer guidelines.
Edge S; Theriault R
J Natl Compr Canc Netw; 2003 Oct; 1 Suppl 3():S-3-8. PubMed ID: 23570131
[TBL] [Abstract][Full Text] [Related]
12. Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer.
Kaufmann M; von Minckwitz G; Mamounas EP; Cameron D; Carey LA; Cristofanilli M; Denkert C; Eiermann W; Gnant M; Harris JR; Karn T; Liedtke C; Mauri D; Rouzier R; Ruckhaeberle E; Semiglazov V; Symmans WF; Tutt A; Pusztai L
Ann Surg Oncol; 2012 May; 19(5):1508-16. PubMed ID: 22193884
[TBL] [Abstract][Full Text] [Related]
13. NCCN Guidelines Insights Breast Cancer, Version 1.2016.
Gradishar WJ; Anderson BO; Balassanian R; Blair SL; Burstein HJ; Cyr A; Elias AD; Farrar WB; Forero A; Giordano SH; Goetz M; Goldstein LJ; Hudis CA; Isakoff SJ; Marcom PK; Mayer IA; McCormick B; Moran M; Patel SA; Pierce LJ; Reed EC; Salerno KE; Schwartzberg LS; Smith KL; Smith ML; Soliman H; Somlo G; Telli M; Ward JH; Shead DA; Kumar R
J Natl Compr Canc Netw; 2015 Dec; 13(12):1475-85. PubMed ID: 26656517
[TBL] [Abstract][Full Text] [Related]
14. Update: NCCN breast cancer clinical practice guidelines.
Carlson RW; Edge SB
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-1-4. PubMed ID: 23570090
[No Abstract] [Full Text] [Related]
15. The curability of breast cancer and the treatment of advanced disease.
Guarneri V; Conte PF
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
[TBL] [Abstract][Full Text] [Related]
16. [Development of guidelines and clinical practice for breast cancer].
Jiang ZF; Li JB
Zhonghua Wai Ke Za Zhi; 2020 Feb; 58(2):85-90. PubMed ID: 32074804
[TBL] [Abstract][Full Text] [Related]
17. [Pathological diagnosis, work-up and reporting of breast cancer. Recommendations of the 3rd Hungarian Consensus Conference on Breast Cancer].
Cserni G; Kulka J; Francz M; Járay B; Kálmán E; Kovács I; Krenács T; Udvarhelyi N; Vass L
Magy Onkol; 2016 Sep; 60(3):209-28. PubMed ID: 27579721
[TBL] [Abstract][Full Text] [Related]
18. Advances in targeting HER2-positive breast cancer.
Harbeck N
Curr Opin Obstet Gynecol; 2018 Feb; 30(1):55-59. PubMed ID: 29194077
[TBL] [Abstract][Full Text] [Related]
19. Trends in breast cancer treatment in Korea and impact of compliance with consensus recommendations on survival.
Yun YH; Park SM; Noh DY; Nam SJ; Ahn SH; Park BW; Lee ES
Breast Cancer Res Treat; 2007 Dec; 106(2):245-53. PubMed ID: 17972176
[TBL] [Abstract][Full Text] [Related]
20. Impact of Oncotype DX breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK.
Loncaster J; Armstrong A; Howell S; Wilson G; Welch R; Chittalia A; Valentine WJ; Bundred NJ
Eur J Surg Oncol; 2017 May; 43(5):931-937. PubMed ID: 28111076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
